Pijnenburg YAL - Search Results

1

Young-onset dementia in memory clinics in the Netherlands: Study design and description of PRECODE-GP.

van Gils AM, Rhodius-Meester HFM, Leeuwis AE, Handgraaf D, Bakker C, Peetoom K, Bouwman FH, Pijnenburg YAL, Papma JM, Hoogendoorn TA, Schoonenboom N, van Strien A, Verwey NA, Köhler S, de Vugt ME, van der Flier WM. van Gils AM, et al. Among authors: pijnenburg yal. Alzheimers Dement (Amst). 2023 Aug 21;15(3):e12471. doi: 10.1002/dad2.12471. eCollection 2023 Jul-Sep. Alzheimers Dement (Amst). 2023. PMID: 37609004 Free PMC article.

2

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Pijnenburg YA, Schoonenboom NS, Scheltens P. Pijnenburg YA, et al. Neurology. 2003 Jan 28;60(2):353-4; author reply 353-4. doi: 10.1212/wnl.60.2.353-a. Neurology. 2003. PMID: 12552068 No abstract available.

3

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC. Rosso SM, et al. Arch Neurol. 2003 Sep;60(9):1209-13. doi: 10.1001/archneur.60.9.1209. Arch Neurol. 2003. PMID: 12975285

4

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P. Schoonenboom NS, et al. Neurology. 2004 May 11;62(9):1580-4. doi: 10.1212/01.wnl.0000123249.58898.e0. Neurology. 2004. PMID: 15136685

5

CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration.

Pijnenburg YA, Schoonenboom NS, Rosso SM, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P. Pijnenburg YA, et al. Neurology. 2004 May 11;62(9):1649. doi: 10.1212/01.wnl.0000123014.03499.a7. Neurology. 2004. PMID: 15136709 No abstract available.

6

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.

Schoonenboom NS, Mulder C, Vanderstichele H, Pijnenburg YA, Van Kamp GJ, Scheltens P, Mehta PD, Blankenstein MA. Schoonenboom NS, et al. Clin Chem. 2005 Jun;51(6):1057-60. doi: 10.1373/clinchem.2005.048629. Epub 2005 Apr 21. Clin Chem. 2005. PMID: 15845801 No abstract available.

7

Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.

van de Pol LA, Hensel A, van der Flier WM, Visser PJ, Pijnenburg YA, Barkhof F, Gertz HJ, Scheltens P. van de Pol LA, et al. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):439-42. doi: 10.1136/jnnp.2005.075341. Epub 2005 Nov 23. J Neurol Neurosurg Psychiatry. 2006. PMID: 16306153 Free PMC article.

8

[Cognitive disorders appearing before the age of 65 in patients of the Alzheimer Centre of the VU Medical Centre: diagnoses and clinical characteristics].

Pijnenburg YA, Zeeman-Rebel A, van der Flier WM, Romkes RM, Gillissen F, Jonker C, Scheltens P. Pijnenburg YA, et al. Ned Tijdschr Geneeskd. 2005 Dec 17;149(51):2862-7. Ned Tijdschr Geneeskd. 2005. PMID: 16398169 Dutch.

9

The effect of APOE genotype on clinical phenotype in Alzheimer disease.

van der Flier WM, Schoonenboom SN, Pijnenburg YA, Fox NC, Scheltens P. van der Flier WM, et al. Neurology. 2006 Aug 8;67(3):526-7. doi: 10.1212/01.wnl.0000228222.17111.2a. Neurology. 2006. PMID: 16894123

10

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.

van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P. van der Flier WM, et al. Dement Geriatr Cogn Disord. 2007;23(1):42-6. doi: 10.1159/000096682. Epub 2006 Oct 31. Dement Geriatr Cogn Disord. 2007. PMID: 17077632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page